Novo Nordisk produces the Ozempic drug for diabetes treatment as well as Wegovy for weight loss, both drugs use semaglutides
Ozempic is typically prescribed for managing blood sugar in people with type 2 diabetes, while Wegovy is mainly prescribed for weight loss in people who are overweight or obese
Alongside thoughtful wrap-around services, there's enormous value in: 3 month bundles of the same dose of medication minimal friction for restarting paused treatments behavioural nudges like text notifications I think this would have an immediate impact & cost much, much less for the patient and for your margin
Semaglutide injections work by triggering GLP-1 receptors in your brain and gut, but where you place the needle influences how quickly your body absorbs the medication
Liu MY, Li HM, Wang XY, Xia R, Li X, Ma YJ, et al
Right now, that trend happens to be medicines used to treat diabetes that also curb hunger: Ozempic and Wegovy